EP0101124B1 - Process for preparing alpha arylalkanoic acids - Google Patents
Process for preparing alpha arylalkanoic acids Download PDFInfo
- Publication number
- EP0101124B1 EP0101124B1 EP83201137A EP83201137A EP0101124B1 EP 0101124 B1 EP0101124 B1 EP 0101124B1 EP 83201137 A EP83201137 A EP 83201137A EP 83201137 A EP83201137 A EP 83201137A EP 0101124 B1 EP0101124 B1 EP 0101124B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- mol
- alpha
- mixture
- acid
- hours
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000002253 acid Substances 0.000 title claims description 18
- 238000004519 manufacturing process Methods 0.000 title claims description 5
- 150000007513 acids Chemical class 0.000 title description 4
- 238000000034 method Methods 0.000 claims description 45
- 239000000203 mixture Substances 0.000 claims description 30
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 8
- 150000002148 esters Chemical class 0.000 claims description 8
- 230000008707 rearrangement Effects 0.000 claims description 8
- 150000003839 salts Chemical class 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 230000007062 hydrolysis Effects 0.000 claims description 6
- 238000006460 hydrolysis reaction Methods 0.000 claims description 6
- 230000007935 neutral effect Effects 0.000 claims description 6
- 239000012429 reaction media Substances 0.000 claims description 3
- 239000000872 buffer Substances 0.000 claims description 2
- 150000003333 secondary alcohols Chemical class 0.000 claims 1
- 150000005846 sugar alcohols Polymers 0.000 claims 1
- 150000003509 tertiary alcohols Chemical class 0.000 claims 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 51
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 44
- 239000000047 product Substances 0.000 description 28
- AZUYLZMQTIKGSC-UHFFFAOYSA-N 1-[6-[4-(5-chloro-6-methyl-1H-indazol-4-yl)-5-methyl-3-(1-methylindazol-5-yl)pyrazol-1-yl]-2-azaspiro[3.3]heptan-2-yl]prop-2-en-1-one Chemical compound ClC=1C(=C2C=NNC2=CC=1C)C=1C(=NN(C=1C)C1CC2(CN(C2)C(C=C)=O)C1)C=1C=C2C=NN(C2=CC=1)C AZUYLZMQTIKGSC-UHFFFAOYSA-N 0.000 description 24
- 235000011056 potassium acetate Nutrition 0.000 description 22
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 8
- 239000011541 reaction mixture Substances 0.000 description 8
- -1 alkali metal alkoxide Chemical class 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 7
- ORTVZLZNOYNASJ-UPHRSURJSA-N (z)-but-2-ene-1,4-diol Chemical compound OC\C=C/CO ORTVZLZNOYNASJ-UPHRSURJSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 238000005160 1H NMR spectroscopy Methods 0.000 description 5
- XBDQKXXYIPTUBI-UHFFFAOYSA-N Propionic acid Substances CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 5
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 4
- XBGGVMCBMDMRIS-UHFFFAOYSA-N 1-(2-bromo-1,1-dimethoxypropyl)-4-methoxybenzene Chemical compound COC1=CC=C(C(OC)(OC)C(C)Br)C=C1 XBGGVMCBMDMRIS-UHFFFAOYSA-N 0.000 description 4
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- 239000002841 Lewis acid Substances 0.000 description 4
- 150000001298 alcohols Chemical class 0.000 description 4
- 125000000217 alkyl group Chemical group 0.000 description 4
- 244000309464 bull Species 0.000 description 4
- 125000004432 carbon atom Chemical group C* 0.000 description 4
- FOTKYAAJKYLFFN-UHFFFAOYSA-N decane-1,10-diol Chemical compound OCCCCCCCCCCO FOTKYAAJKYLFFN-UHFFFAOYSA-N 0.000 description 4
- 229910052736 halogen Inorganic materials 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 150000007517 lewis acids Chemical class 0.000 description 4
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 4
- SLCVBVWXLSEKPL-UHFFFAOYSA-N neopentyl glycol Chemical compound OCC(C)(C)CO SLCVBVWXLSEKPL-UHFFFAOYSA-N 0.000 description 4
- 235000013772 propylene glycol Nutrition 0.000 description 4
- DNIAPMSPPWPWGF-VKHMYHEASA-N (+)-propylene glycol Chemical compound C[C@H](O)CO DNIAPMSPPWPWGF-VKHMYHEASA-N 0.000 description 3
- YPFDHNVEDLHUCE-UHFFFAOYSA-N 1,3-propanediol Substances OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 3
- 229940035437 1,3-propanediol Drugs 0.000 description 3
- JLWOBZAQVNJHCA-UHFFFAOYSA-N 2-(1-bromoethyl)-2-(4-methoxyphenyl)-1,3-dioxane Chemical compound C1=CC(OC)=CC=C1C1(C(C)Br)OCCCO1 JLWOBZAQVNJHCA-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 239000003377 acid catalyst Substances 0.000 description 3
- XXROGKLTLUQVRX-UHFFFAOYSA-N allyl alcohol Chemical compound OCC=C XXROGKLTLUQVRX-UHFFFAOYSA-N 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- 150000002367 halogens Chemical class 0.000 description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 3
- 229920000166 polytrimethylene carbonate Polymers 0.000 description 3
- UBWMJDOJXJEORL-UHFFFAOYSA-N 1-(2-bromo-1,1-dimethoxypropyl)-4-(2-methylpropyl)benzene Chemical compound COC(OC)(C(C)Br)C1=CC=C(CC(C)C)C=C1 UBWMJDOJXJEORL-UHFFFAOYSA-N 0.000 description 2
- 125000006083 1-bromoethyl group Chemical group 0.000 description 2
- JEONLNNPACVLDA-UHFFFAOYSA-N 2-(1-bromoethyl)-2-(4-methoxyphenyl)-1,3-dioxolane Chemical compound C1=CC(OC)=CC=C1C1(C(C)Br)OCCO1 JEONLNNPACVLDA-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 2
- MITFXPHMIHQXPI-UHFFFAOYSA-N Oraflex Chemical compound N=1C2=CC(C(C(O)=O)C)=CC=C2OC=1C1=CC=C(Cl)C=C1 MITFXPHMIHQXPI-UHFFFAOYSA-N 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 2
- 125000003545 alkoxy group Chemical group 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 125000005843 halogen group Chemical group 0.000 description 2
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 2
- 239000001294 propane Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- RJMIEHBSYVWVIN-LLVKDONJSA-N (2r)-2-[4-(3-oxo-1h-isoindol-2-yl)phenyl]propanoic acid Chemical compound C1=CC([C@H](C(O)=O)C)=CC=C1N1C(=O)C2=CC=CC=C2C1 RJMIEHBSYVWVIN-LLVKDONJSA-N 0.000 description 1
- RDJGLLICXDHJDY-NSHDSACASA-N (2s)-2-(3-phenoxyphenyl)propanoic acid Chemical compound OC(=O)[C@@H](C)C1=CC=CC(OC=2C=CC=CC=2)=C1 RDJGLLICXDHJDY-NSHDSACASA-N 0.000 description 1
- MDKGKXOCJGEUJW-VIFPVBQESA-N (2s)-2-[4-(thiophene-2-carbonyl)phenyl]propanoic acid Chemical compound C1=CC([C@@H](C(O)=O)C)=CC=C1C(=O)C1=CC=CS1 MDKGKXOCJGEUJW-VIFPVBQESA-N 0.000 description 1
- PAMIQIKDUOTOBW-UHFFFAOYSA-N 1-methylpiperidine Chemical compound CN1CCCCC1 PAMIQIKDUOTOBW-UHFFFAOYSA-N 0.000 description 1
- AVFZOVWCLRSYKC-UHFFFAOYSA-N 1-methylpyrrolidine Chemical compound CN1CCCC1 AVFZOVWCLRSYKC-UHFFFAOYSA-N 0.000 description 1
- HEWZVZIVELJPQZ-UHFFFAOYSA-N 2,2-dimethoxypropane Chemical compound COC(C)(C)OC HEWZVZIVELJPQZ-UHFFFAOYSA-N 0.000 description 1
- RIKQUMLWFMJDEP-UHFFFAOYSA-N 2-(1-bromoethyl)-2-[4-(2-methylpropyl)phenyl]-4,7-dihydro-1,3-dioxepine Chemical compound C1=CC(CC(C)C)=CC=C1C1(C(C)Br)OCC=CCO1 RIKQUMLWFMJDEP-UHFFFAOYSA-N 0.000 description 1
- SDIMNXAVQQOPOA-UHFFFAOYSA-N 2-(1-bromoethyl)-5,5-dimethyl-2-[4-(2-methylpropyl)phenyl]-1,3-dioxane Chemical compound C1=CC(CC(C)C)=CC=C1C1(C(C)Br)OCC(C)(C)CO1 SDIMNXAVQQOPOA-UHFFFAOYSA-N 0.000 description 1
- GBVJENRFWPBYAC-UHFFFAOYSA-N 2-(1-chloroethyl)-5,5-dimethyl-2-[4-(2-methylpropyl)phenyl]-1,3-dioxane Chemical compound C1=CC(CC(C)C)=CC=C1C1(C(C)Cl)OCC(C)(C)CO1 GBVJENRFWPBYAC-UHFFFAOYSA-N 0.000 description 1
- RYDUZJFCKYTEHX-UHFFFAOYSA-N 2-(2-propan-2-yl-2,3-dihydro-1h-inden-5-yl)propanoic acid Chemical compound C1=C(C(C)C(O)=O)C=C2CC(C(C)C)CC2=C1 RYDUZJFCKYTEHX-UHFFFAOYSA-N 0.000 description 1
- KBDLTYNZHQRMQC-UHFFFAOYSA-N 2-(4-methoxyphenyl)propanoic acid Chemical compound COC1=CC=C(C(C)C(O)=O)C=C1 KBDLTYNZHQRMQC-UHFFFAOYSA-N 0.000 description 1
- ACUZDYFTRHEKOS-SNVBAGLBSA-N 2-Decanol Natural products CCCCCCCC[C@@H](C)O ACUZDYFTRHEKOS-SNVBAGLBSA-N 0.000 description 1
- JIEKMACRVQTPRC-UHFFFAOYSA-N 2-[4-(4-chlorophenyl)-2-phenyl-5-thiazolyl]acetic acid Chemical compound OC(=O)CC=1SC(C=2C=CC=CC=2)=NC=1C1=CC=C(Cl)C=C1 JIEKMACRVQTPRC-UHFFFAOYSA-N 0.000 description 1
- UHRGECMJNZBPBT-UHFFFAOYSA-N 4-(2-bromoethyl)-2-(4-methoxyphenyl)-4,7-dihydro-1,3-dioxepine Chemical compound C1=CC(OC)=CC=C1C1OC(CCBr)C=CCO1 UHRGECMJNZBPBT-UHFFFAOYSA-N 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 1
- AHVYPIQETPWLSZ-UHFFFAOYSA-N N-methyl-pyrrolidine Natural products CN1CC=CC1 AHVYPIQETPWLSZ-UHFFFAOYSA-N 0.000 description 1
- CMWTZPSULFXXJA-UHFFFAOYSA-N Naproxen Natural products C1=C(C(C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-UHFFFAOYSA-N 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 229960005142 alclofenac Drugs 0.000 description 1
- ARHWPKZXBHOEEE-UHFFFAOYSA-N alclofenac Chemical compound OC(=O)CC1=CC=C(OCC=C)C(Cl)=C1 ARHWPKZXBHOEEE-UHFFFAOYSA-N 0.000 description 1
- 125000002723 alicyclic group Chemical group 0.000 description 1
- 229910001854 alkali hydroxide Inorganic materials 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 229910001860 alkaline earth metal hydroxide Inorganic materials 0.000 description 1
- 125000003302 alkenyloxy group Chemical group 0.000 description 1
- 150000004808 allyl alcohols Chemical group 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 238000010533 azeotropic distillation Methods 0.000 description 1
- 229960005430 benoxaprofen Drugs 0.000 description 1
- 125000004541 benzoxazolyl group Chemical group O1C(=NC2=C1C=CC=C2)* 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 125000000068 chlorophenyl group Chemical group 0.000 description 1
- 238000005056 compaction Methods 0.000 description 1
- 229910000366 copper(II) sulfate Inorganic materials 0.000 description 1
- 125000000753 cycloalkyl group Chemical group 0.000 description 1
- ACUZDYFTRHEKOS-UHFFFAOYSA-N decan-2-ol Chemical compound CCCCCCCCC(C)O ACUZDYFTRHEKOS-UHFFFAOYSA-N 0.000 description 1
- 239000012024 dehydrating agents Substances 0.000 description 1
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 description 1
- 229960001259 diclofenac Drugs 0.000 description 1
- DCOPUUMXTXDBNB-UHFFFAOYSA-N diclofenac Chemical compound OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl DCOPUUMXTXDBNB-UHFFFAOYSA-N 0.000 description 1
- 125000005054 dihydropyrrolyl group Chemical group [H]C1=C([H])C([H])([H])C([H])([H])N1* 0.000 description 1
- 150000002009 diols Chemical class 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- 150000002084 enol ethers Chemical class 0.000 description 1
- IDKAXRLETRCXKS-UHFFFAOYSA-N fenclofenac Chemical compound OC(=O)CC1=CC=CC=C1OC1=CC=C(Cl)C=C1Cl IDKAXRLETRCXKS-UHFFFAOYSA-N 0.000 description 1
- 229950006236 fenclofenac Drugs 0.000 description 1
- 229960001419 fenoprofen Drugs 0.000 description 1
- 229960002679 fentiazac Drugs 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 229960002390 flurbiprofen Drugs 0.000 description 1
- SYTBZMRGLBWNTM-UHFFFAOYSA-N flurbiprofen Chemical compound FC1=CC(C(C(O)=O)C)=CC=C1C1=CC=CC=C1 SYTBZMRGLBWNTM-UHFFFAOYSA-N 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 229960001680 ibuprofen Drugs 0.000 description 1
- 125000003387 indolinyl group Chemical group N1(CCC2=CC=CC=C12)* 0.000 description 1
- 229960004187 indoprofen Drugs 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 229950000704 isoprofen Drugs 0.000 description 1
- 238000005907 ketalization reaction Methods 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- DKYWVDODHFEZIM-UHFFFAOYSA-N ketoprofen Chemical compound OC(=O)C(C)C1=CC=CC(C(=O)C=2C=CC=CC=2)=C1 DKYWVDODHFEZIM-UHFFFAOYSA-N 0.000 description 1
- 229960000991 ketoprofen Drugs 0.000 description 1
- 125000005905 mesyloxy group Chemical group 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 239000002808 molecular sieve Substances 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 229910052901 montmorillonite Inorganic materials 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 229960002009 naproxen Drugs 0.000 description 1
- CMWTZPSULFXXJA-VIFPVBQESA-N naproxen Chemical compound C1=C([C@H](C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-VIFPVBQESA-N 0.000 description 1
- BTSIZIIPFNVMHF-UHFFFAOYSA-N nor-leaf alcohol Natural products CCC=CCO BTSIZIIPFNVMHF-UHFFFAOYSA-N 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 125000000168 pyrrolyl group Chemical group 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 229960004492 suprofen Drugs 0.000 description 1
- 125000000335 thiazolyl group Chemical group 0.000 description 1
- 125000001544 thienyl group Chemical group 0.000 description 1
- 229960001017 tolmetin Drugs 0.000 description 1
- UPSPUYADGBWSHF-UHFFFAOYSA-N tolmetin Chemical compound C1=CC(C)=CC=C1C(=O)C1=CC=C(CC(O)=O)N1C UPSPUYADGBWSHF-UHFFFAOYSA-N 0.000 description 1
- 125000005424 tosyloxy group Chemical group S(=O)(=O)(C1=CC=C(C)C=C1)O* 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 229950005298 xenbucin Drugs 0.000 description 1
- IYEPZNKOJZOGJG-UHFFFAOYSA-N xenbucin Chemical compound C1=CC(C(C(O)=O)CC)=CC=C1C1=CC=CC=C1 IYEPZNKOJZOGJG-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/475—Preparation of carboxylic acid esters by splitting of carbon-to-carbon bonds and redistribution, e.g. disproportionation or migration of groups between different molecules
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
- C07C69/734—Ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D321/00—Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups C07D317/00 - C07D319/00
- C07D321/02—Seven-membered rings
- C07D321/04—Seven-membered rings not condensed with other rings
- C07D321/06—1,3-Dioxepines; Hydrogenated 1,3-dioxepines
Definitions
- This invention relates to a process for preparing an alpha-arylalkanoic acid or a salt thereof which comprises the rearrangement of an alpha-halo-alkylarylketal in neutral or weakly alkaline conditions and in the presence of a polar-protic medium and the subsequent hydrolysis of the thus obtained ester in the same reaction medium to afford the corresponding alpha-arylalkanoic acid.
- the European Patent Application 34871 describes a process for preparing esters of alpha-arylalkanoic acids via rearrangement of alpha-halo-alkylarylketals in the presence of a Lewis acid.
- the disadvantages of this process are that the reaction must be carried out in an anhydrous medium and that the more effective Lewis acids are the salts of toxic heavy metals; consequently there is a need for a careful purification when the final product is intended for pharmaceutical use.
- This purification step may be carried out successfully by isolating the ester but this impairs the compaction of both the rearrangement and the hydrolysis steps.
- Lewis acids incline to interact with the oxygen atoms of the ketal group and, consequently, to form by-products whose amount ranges in accordance with the nature of the alpha-halo-alkylarylketal and of the Lewis acid which are used.
- the European Application No. 48.136 describes a process for preparing alpha-arylalkanoic acids wherein an alpha-sulfonyloxyketal undergoes hydrolysis. This process lays on the prejudice that the halogen atom is not sufficiently labile to promote the rearrangement in the absence of a catalyst having affinity for halogen whereas it was well known that the sulfonyloxy-groups like the tosyloxy and mesyloxy are sufficiently labile to disassociate from the substrate upon contact with a protic-polar medium.
- the process according to this invention comprises the rearrangement of an alpha-haloalkylarylketal in neutral or weakly alkaline conditions and in the presence of a polar-protic medium and the subsequent hydrolysis of the thus obtained ester in the same reaction medium to afford the corresponding alpha-arylalkanoic acid or a salt thereof.
- the neutral or weakly alkaline condition is obtained by adding buffers or weak bases either organic or inorganic or mixture thereof.
- buffers or weak bases either organic or inorganic or mixture thereof.
- typical compounds are the aliphatic and the aromatic tertiary amines and the alkali and alkaline earth metals salts of organic and inorganic acids such as sodium bicarbonate, calcium carbonate, potassium acetate, triethylamine, methylpiperidine, methyl pyrrolidine and dimethylaniline.
- the protic-polar media according to this invention are water, alcohols and mixtures thereof.
- alcohols include C l -C, 2 primary, secondary and terziary alcohols and C 2 -C 12 polhydric alcohols such as methanol, ethanol, butanol, isobutanol, sec butanol, 2-decanol, allyl alcohol, ethylene glycol, 1,2-propanediol, 1,3-propanediol, 1,10-decanediol, cis-2-buten-1,4-diol and the like.
- the choice of the protic medium will depend from its lipophilic acnd hydrophilic properties as well as from the nature of the alpha-halo-alkylarylketal.
- reaction time is comprised between few minutes and about twelve hours when a ketal endowed with a normal reactivity is treated at a temperature from 80°C to 200°C.
- the pH of the reaction mixture is made acid or basic for hydrolyzing the ester.
- the pH is increased by addition of a base.
- suitable bases include alkali and alkaline earth metal hydroxides and salts.
- this step is complete in a time period comprised from few minutes and some hours at a temperature from 20° to 100°C. It is so obtained a salt of an alpha-arylalkanoic acid which is then treated, when desired, with an acid to afford the free alpha-arylalkanoic acid.
- arylalkanoic acids which may be prepared with the process of this invention include aclofenac, benoxaprofen, caroprofen, diclofenac, fenclofenac, fenoprofen, fentiazac, flurbiprofen, indoprofen, ibuprofen, isoprofen, ketoprofen, naproxen, piroprofen, suprofen, tolmetin, xenbucin and the like.
- the alpha-halo-alkylarylketals may be prepared according to known methods.
- Examples of methods suitable for preparing alpha-halo-alkylarylketals contemplate the use of an acid catalyst such as p-toluenesulfonic acid (J. Org. Chem. 21,1366 (1956); ibidem, 22, 662, (1957); Synthesis 23, (1974), active montmorillonite (Bull. Soc. Chim. France, 2558, (1975)), BF 3 etherate (Bull. Soc. Chim. France 1763 (1975)) and citric acid (U.S. Patent 3.936.398).
- An improvement to the last method contemplates the use of citric acid in the presence of hydroquinone which acts as polymerization inhibitor (Bull. Soc. Chim. France, 1973 (1975)).
- the water generated in the course of the reaction is removed by azeotropic distillation with suitable solvents such as benzene, toluene, cyclohexane and the like or by means of a dehydrating agent such as anhydrous CuS0 4 , a trialkylorthoformate, molecular sieves and the like (Synthesis, 501 (1981).
- ketals Other known methods for preparing the ketals are the trans-ketalization, the reaction of a ketone with an alcohol in the presence of a ketal such as 2,2-dimethoxypropane and an acid catalyst (J. Org. Chem. 25, 521 (1960)) and the reaction of an alcohol with a suitable enol-ether in the presence of an acid catalyst (Bull. Soc. Chim. France, 264 (1979)).
- alpha-halo-alkylarylketals examples include:
- Particularly useful new alpha-halo-alkylarylketals of formula I are those where R' and R" together are a straight or branched unsatured alkylidene radical which forms a ring having 7 members. They are described by the Italian Patent Application No. 19930 A/83 filed on March 7, 1983 and are an object of the European Patent Application No. 83201136.5 filed on August 1, 1983.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Description
- This invention relates to a process for preparing an alpha-arylalkanoic acid or a salt thereof which comprises the rearrangement of an alpha-halo-alkylarylketal in neutral or weakly alkaline conditions and in the presence of a polar-protic medium and the subsequent hydrolysis of the thus obtained ester in the same reaction medium to afford the corresponding alpha-arylalkanoic acid.
- The European Patent Application 34871 describes a process for preparing esters of alpha-arylalkanoic acids via rearrangement of alpha-halo-alkylarylketals in the presence of a Lewis acid. The disadvantages of this process are that the reaction must be carried out in an anhydrous medium and that the more effective Lewis acids are the salts of toxic heavy metals; consequently there is a need for a careful purification when the final product is intended for pharmaceutical use. This purification step may be carried out successfully by isolating the ester but this impairs the compaction of both the rearrangement and the hydrolysis steps.
- Furthermore the Lewis acids incline to interact with the oxygen atoms of the ketal group and, consequently, to form by-products whose amount ranges in accordance with the nature of the alpha-halo-alkylarylketal and of the Lewis acid which are used.
- The European Application No. 48.136 describes a process for preparing alpha-arylalkanoic acids wherein an alpha-sulfonyloxyketal undergoes hydrolysis. This process lays on the prejudice that the halogen atom is not sufficiently labile to promote the rearrangement in the absence of a catalyst having affinity for halogen whereas it was well known that the sulfonyloxy-groups like the tosyloxy and mesyloxy are sufficiently labile to disassociate from the substrate upon contact with a protic-polar medium.
- Despite the apparent ease of the last step this process is complex and cumbersome owing to the fact that at first an alpha-haloketone is reacted with an alkali metal alkoxide to afford an alpha-hydroxyketal which is then treated with an O-sulfonylating agent to form the corresponding alpha-sulfonyloxyketal and finally the alpha-sulfonyloxyketal is submitted to hydrolysis. The number of steps involved and the difficulties inherent in carrying out on a large scale some of the steps leave room for a more simple and economical process.
- Now it has been surprisingly found that the alpha-haloalkyl aryl ketals undergo rearrangement in neutral or weakly alkaline conditions and in the presence of a protic-polar medium thus avoiding the detour depicted by the European Patent Application 48.136 as well as disadvantages inherent in the process described by the European Patent Application 34.871.
- More particularly the process according to this invention comprises the rearrangement of an alpha-haloalkylarylketal in neutral or weakly alkaline conditions and in the presence of a polar-protic medium and the subsequent hydrolysis of the thus obtained ester in the same reaction medium to afford the corresponding alpha-arylalkanoic acid or a salt thereof.
- The neutral or weakly alkaline condition is obtained by adding buffers or weak bases either organic or inorganic or mixture thereof. Examples of typical compounds are the aliphatic and the aromatic tertiary amines and the alkali and alkaline earth metals salts of organic and inorganic acids such as sodium bicarbonate, calcium carbonate, potassium acetate, triethylamine, methylpiperidine, methyl pyrrolidine and dimethylaniline.
- The protic-polar media according to this invention are water, alcohols and mixtures thereof. Examples of alcohols include Cl-C,2 primary, secondary and terziary alcohols and C2-C12 polhydric alcohols such as methanol, ethanol, butanol, isobutanol, sec butanol, 2-decanol, allyl alcohol, ethylene glycol, 1,2-propanediol, 1,3-propanediol, 1,10-decanediol, cis-2-buten-1,4-diol and the like.
- Preferably the choice of the protic medium will depend from its lipophilic acnd hydrophilic properties as well as from the nature of the alpha-halo-alkylarylketal.
- As a rule a decrease in the concentration of the hydroxy- groups such as in the alcohol and diols having a long aliphatic chain, increases the lipophilic property of the protic medium and in its turn promotes the solubilization of the low-polar ketals but reduces their reaction rate which; on the contrary is favored by strongly hydrophilic protic media. Of course, the reaction rate is increased also by an increase in the reaction temperature.
- Usually the reaction time is comprised between few minutes and about twelve hours when a ketal endowed with a normal reactivity is treated at a temperature from 80°C to 200°C.
- When the rearrangement is complete the pH of the reaction mixture is made acid or basic for hydrolyzing the ester. Preferably the pH is increased by addition of a base. Example of suitable bases include alkali and alkaline earth metal hydroxides and salts. Usually this step is complete in a time period comprised from few minutes and some hours at a temperature from 20° to 100°C. It is so obtained a salt of an alpha-arylalkanoic acid which is then treated, when desired, with an acid to afford the free alpha-arylalkanoic acid.
- Examples of arylalkanoic acids which may be prepared with the process of this invention include aclofenac, benoxaprofen, caroprofen, diclofenac, fenclofenac, fenoprofen, fentiazac, flurbiprofen, indoprofen, ibuprofen, isoprofen, ketoprofen, naproxen, piroprofen, suprofen, tolmetin, xenbucin and the like.
-
- Ar is an aromatic ring selected from the group comprising (a) a phenyl ring substituted by one or two substituents selected from the group comprising halogen, 1-6 C alkyl, 1-4 C alkoxy, 2-4 C alkenyloxy, phenyl, phenoxy, dichlorophenoxy, dichloroanilino, benzoyl, indolinyl, dihydropyrrolyl, thenoyl (b) a naphthyl ring substituted by one or two substituents selected from the group comprising halogen and 1-4 C alkoxy (c) a pyrrolyl ring substituted by one or two radicals selected from the group comprising 1-4 C alkyl and alkyl 1-4 C-phenyl, (d) chloro-carbazolyl, (e) benzoxazolyl substituted by one chlorophenyl radical, (f) thiazolyl substituted by one or two radical selected from the group comprising phenyl and chlorophenyl, and (g) thienyl,
- R' and R", independently from each other, are a satured or unsatured, straight or branched alkyl radical having from 1 to 12 C atoms or, when taken together, are a satured or unsatured straight or branched alkylene radical having from 2 to 12 C atoms which completes an alicyclic ring having from 5 to 7 members,
- X is halogen;
- R'" is hydrogen, alkyl having from 1 to 6 C atoms or cycloalkyl having from 1 to 7 C atoms.
- The alpha-halo-alkylarylketals may be prepared according to known methods.
- Examples of methods suitable for preparing alpha-halo-alkylarylketals contemplate the use of an acid catalyst such as p-toluenesulfonic acid (J. Org. Chem. 21,1366 (1956); ibidem, 22, 662, (1957); Synthesis 23, (1974), active montmorillonite (Bull. Soc. Chim. France, 2558, (1975)), BF3 etherate (Bull. Soc. Chim. France 1763 (1975)) and citric acid (U.S. Patent 3.936.398). An improvement to the last method contemplates the use of citric acid in the presence of hydroquinone which acts as polymerization inhibitor (Bull. Soc. Chim. France, 1973 (1975)).
- The water generated in the course of the reaction is removed by azeotropic distillation with suitable solvents such as benzene, toluene, cyclohexane and the like or by means of a dehydrating agent such as anhydrous CuS04, a trialkylorthoformate, molecular sieves and the like (Synthesis, 501 (1981).
- Other known methods for preparing the ketals are the trans-ketalization, the reaction of a ketone with an alcohol in the presence of a ketal such as 2,2-dimethoxypropane and an acid catalyst (J. Org. Chem. 25, 521 (1960)) and the reaction of an alcohol with a suitable enol-ether in the presence of an acid catalyst (Bull. Soc. Chim. France, 264 (1979)).
- Examples of known alpha-halo-alkylarylketals include:
- ―2-bromo-1,1-dimethoxy-1-(6'-methoxy-2'-naphthyl)-propane,
- ― 2-bromo-1,1-dimethoxy-1-(4'-isobutylphenyl)-propane,
- ―2-(1'-bromoethyl)-2-(6'-methoxy-2'-naphthyl)-1,3-dioxane, and
- ― 2-(1'-bromoethyl)-2-(6'-methoxy-2'-naphthyl)-1,3-dioxolane.
- Examples of not-yet described alpha-halo-alkylarylketals which are prepared according to known techniques are:
- 2-bromo-1,1-dimethoxy-1-(4'-methoxyphenyl)-propane
- 1H-NMR (60 MHz) (CDCl3―TMS) delta (ppm): 1.45 (d, 3H); 3.15 (s, 3H); 3.8 (s, 3H); 4.5 (q, 1H); 6.85―7.6 (m, 4H).
- 2-bromo-1,1-dimethoxy-1-(4'-isobutylphenyl)-propane
- 'H-NMR (60 MHz) (CDCI3-TMS) delta (ppm); 0.9 (d, 6H); 1.5 (d, 3H); 1.7-2.2 (m, 1 H); 2.6 (d, 2H); 3.2 (s, 3H); 3.4 (s, 3H); 4.5 (q, 1H); 7.1-7.6 (m, 4H).
- 2-(1'-bromoethyl)-5,5-dimethyl-2-(6'-methoxy-2'-naphthyl)-1,3-dioxane, m.p. 89-90°C. 2-(1'-bromoethyl)-2-(4'-methoxyphenyl)-1,3-dioxane
- 1H-NMR (60 MHz) (CDCl3―TMS) delta (ppm): 1.65 (3, 3H), 3.6-4 (m, 6H); 3.85 (s, 3H); 4.1 (q, 1H); 7-7.7 (m, 4H).
- 2-(1'-bromoethyl)-2-(6'-methoxy-2'-naphthyl)-1,3-dioxane
- 1H-NMR (60 MHz) (CDCl3―TMS) delta (ppm): 1.20 (m, 2H); 1.68 (d, 3H); 3.90 (m, 4H); 3.96 (s, 3H); 4.30 (q, 1H); 7.12-7.98 (m, 6H).
- 2-(1'-bromoethyl)-5-(2'-butyl)-5-methyl-2-(4'-methoxyphenyl)-1,3-dioxane,
- 2-(1'-bromoethyl)-5,5-dimethyl-2-(4'-isobutylphenyl)-2,3-dioxane, b.p. 135-138°C (0.6 mm Hg)
- 2-(1'-bromoethyl)-5,5-dimethyl-2-(5'-bromo-6'-methoxy-2'-naphthyl)-1,3-dioxane, m.p. 143-145°C
- 2-(1'-bromoethyl)-5,5-dimethyl-2-(2'-thienyl)-1,3-dioxane, b.p. 78-80°C (0.5 mm Hg)
- 2-(1'-bromoethyl)-2-(4'-methoxyphenyl)-1,3-dioxolane
- 'H-NMR (60 MHz) (CDCI3-TMS) (ppm); 1.6 (d, 3H), 3.8 (s, 3H); 3.8-4.2 (m, 4H); 4.4 (q, 1H); 6.85-7.6 (m, 4H)
- Particularly useful new alpha-halo-alkylarylketals of formula I are those where R' and R" together are a straight or branched unsatured alkylidene radical which forms a ring having 7 members. They are described by the Italian Patent Application No. 19930 A/83 filed on March 7, 1983 and are an object of the European Patent Application No. 83201136.5 filed on August 1, 1983.
- The following examples are given to illustrate this invention without limiting it in any way.
-
- a) A mixture of 2 - bromo -1,1- dimethoxy - 2 - (6' - methoxy - 2' - naphthyl)propane (3.39 g; 0.01 mol), potassium acetate (1.2 g; 0.012 mol) and 1,10-decane diol (5 g) is heated to 170°C for six hours. After having reduced the temperature to 70°C and added 30% potassium hydroxide, the reaction mixture is heated to 100°C for five hours. The mixture is then cooled to room temperature, poured into water (100 ml) and extracted with methylene chloride (3x100 ml). The aqueous layer is acidified with concentrated hydrochloric acid to afford a precipitate consisting of 2 - (6' - methoxy - 2' - naphthyl) - propionic acid (1.38 g; 0.006 mol). Yield, 60%; m.p. 155-156°C.
- b) By substituting ethylene glycol (40 ml) for 1,10-decanediol in the procedure of Example 1a and otherwise heating the reaction mixture to 125°C for 8 hours, there is obtained the title product (1.9 g; 0.0082 mol). Yield, 82%; m.p. 155-157°C.
- c) By substituting allyl alcohol (50 ml) for 1,10-decanediol in the procedure of Example 1a and otherwise refluxing the reaction mixture for 48 hours, there is obtained the title product (1.2 g; 0.0052 mol). Yield, 52%; m.p. 155-156°C.
- d) A mixture of 2 - (1' - bromoethyl) - 2 - (6' - methyl - 2' - naphthyl) - 1,3 - dioxolane (3.37 g; 0.01 mol), potassium acetate (1.2 g; 0.012 mol) and ethylene glycol (50 ml) is heated to 125°C for 16 hours.
- By following the procedure of Example 1a, there is obtained the title product (1.61 g; 0.007 mol). Yield, 70%; m.p. 155-156°C.
- e) A mixture of 2 - (1' - bromoethyl) - 2 - (6' - methoxy - 2' - naphthyl) - 1,3 - dioxolane (2.68 g; 0.008 mol), disodium phosphate (1.36 g; 0.0095 mol), monopotassium phosphate (1.44 g; 0.01 mol) and ethylene glycol (40 ml) is heated to 125°C for 16 hours.
- By following the procedure of Example 1a, there is obtained the title product (1.25; 0.005 mol). Yield, 62.5%; m.p. 155-156°C.
- f) A mixture of 2-(1'- bromoethyl) - 2 - (6' - methoxy - 2' - naphthyl) - 1,3 - dioxolane (13.48 g; 0.042 mol), potassium bicarbonate (6 g; 0.06 mol) and ethylene glycol (200 ml) is heated to 125°C for 18 hours.
- By following the procedure of Example 1a, there is obtained the title product (6.91 g; 0.03 mol). Yield, 71,5%; m.p. 155―156°C.
- g) A mixture of 2 - (1' - bromoethyl) - 2 - (6' - methoxy - 2' - naphthyl) -1,3 - dioxane (3.51 g; 0.01 mol), potassium acetate (1.2 g; 0.012 mol) and 1,3-propanediol (50 ml) is heated to 125°C for 8 hours.
- By following the procedure of Example 1a, there is obtained the title product (2.25 g; 0.0098 mol). Yield, 98%; m.p. 155-156°C.
- h) A mixture of 2 - -(1' - bromoethyl) - 5,5 - dimethyl - 2 - (6' - methoxy - 2' - naphthyl) - 1,3 - dioxane (3.79 g; 0.01 mol), potassium acetate (1.2 g; 0.012 mol) and ethylene glycol (40 ml) is heated to 125°C for 4 hours.
- By following the procedure of Example 1a, there is obtained the title product (2.1 g; 0.0091 mol). Yield, 91%; m.p. 154-155°C.
- i) A mixture of 2 - (6' - methoxy - 2' - naphthyl) - 2 - (1' - bromoethyl) - 4,7 - dihydro - 1,3 - dioxepine (1.09 g; 0.003 mol), cis - 2 - butene - 1,4 - diol (10 ml) and potassium acetate (0.40 g;
- 0.004 mol) is heated to 125°C for 1 hour.
- By following the procedure of Example 1a, there is obtained the title product (0.6 g; 0.0026 mol). Yield, 87%; m.p. 155-156°C.
- I) A mixture of 2 - (1' - bromoethyl) - 2 - (6' - methoxy - 2' - naphthyl) - 1,3 - dioxolane (3.37 g; 0.01 mol), potassium acetate (1.2 g; 0.012 mol) and 2,2 - dimethyl - 1,3 - propanediol (30 g) is heated to 150°C for 24 hours.
- By following the procedure of Example 1a, there is obtained the title product (1.61 g; 0.007 mol). Yield, 70%; m.p. 155-156°C.
-
- a) A mixture of 2-bromo - 1,1 - dimethoxy -1 - (4' - methoxyphenyl) - propane (2.89 g; 0.01 mol), calcium carbonate (1 g; 0.01 mol), methanol (7 ml) and water (3 ml) is refluxed for 35 hours. The reaction mixture is then cooled to 25°C and worked up as described in Example 1a, there is so obtained the title product (1.69 g; 0.0094 mol). Yield, 94%; m.p, 55°C.
- b) A mixture of 2 - bromo - 1,1 - dimethoxy -1 - (4' - methoxyphenyl) - propane (2.89 g; 0.01 mol), potassium acetate (1.2 g; 0.012 mol), 1,2-propanediol (16 ml) and water (8 ml) is heated to 95°C for 3 hours.
- By following the procedure of Example 1, there is obtained the title product (1.71 g; 0.0095 mol). Yield, 95%; m.p. 57°C.
- c) A mixture of 2 - bromo - 1,1 - dimethoxy - 1 - (4' - methoxyphenyl) - propane (2.89 g; 0.01 mol), potassium acetate (1.2 g; 0.012 mol) and n-butanol (40 ml) is heated to 115°C for 32 hours.
- By following the procedure of Example 1a, there is obtained the title product (1.60 g; 0.0089 mol). Yield, 89%; m.p. 56-57°C.
- d) A mixture of 2 - (1 - bromoethyl) - 2 - (4' - methoxyphenyl) - 1,3 - dioxane (3.01 g; 0.01 mol), potassium acetate (1.2 g; 0.012 mol) and ethylene glycol (40 ml) is heated to 115°C for 4 hours.
- By following the procedure of Example 1, there is obtained the title product (1.70 g; 0.0094 mol). Yield, 94%; m.p. 56-57°C.
- e) A mixture of 2 - (1 - bromoethyl) - 2 - (4' - methoxyphenyl) - 1,3 - dioxane (3.01 g; 0.01 mol), potassium acetate (1.2 g; 0.012 mol) and 1,3-propanediol (40 ml) is heated to 115°C for 4 hours.
- By following the procedure of Example 1a, there is obtained the title product (1.73 g; 0.0096 mol). Yield, 96%; m.p. 57°C.
- f) A mixture of 2 - (1' - bromoethyl) - 2 - (4' - methoxyphenyl) - 1,3 - dioxolane (2.87 g; 0.01 mol), potassium acetate (1.2 g; 0.012 mol) and ethylene glycol (40 ml) is heated to 115°C for 15 hours.
- By following the procedure of Example 1a, there is obtained the title product (1.44 g; 0.008 mol). Yield, 80%; m.p. 57°C.
- g) A mixture of 2 - (1 - bromoethyl) - 5 - (2' - butyl) - 5 - methyl - 2 - (4' - methoxyphenyl) - 1,3 - dioxane (3.68 g; 0.01 mol), ethylene glycol (40 ml) and potassium acetate (1.2 g; 0.012 mol) is heated to 125°C for 4 hours.
- By following the procedure of Example 1a, there is obtained the title product (1.7 g; 0.0094 mol). Yield, 94%; m.p. 56°C.
- h) A mixture of 2 - (1' - bromoethyl) - 2 - (4' - methoxy) - 4,7 - dihydro - 1,3 - dioxepine (3.13 g; 0.01 mol), potassium acetate (1.2 g; 0.012 mol) and ethylene glycol (40 ml) is heated to 115°C for 1 hour.
- By following the procedure of Example 1a, there is obtained the title product (1.52 g; 0.0085 mol). Yield, 85%; m.p. 57°C.
- i) By substituting cis - 2 - butene - 1,4 - diol (40 ml) for ethylene glycol in Example 2h, and otherwise heating the reaction mixture to 125°C for 3 hours and then following the procedure of Example 1a, there is obtained the title product (1.52 g; 0.0085 mol). Yield, 85%; m.p. 55-57°C.
-
- a) A mixture of 2 - bromo - 1,1 - dimethoxy - 1 - (4' - isobutylphenyl) - propane (3.15 g; 0.01 mol), potassium acetate (12 g; 0.012 mol), n-butanol (12 ml), 1,2-propanediol (16 ml) and water is heated to 95°C for 67 hours.
- By following the procedure of Example 1a, there is obtained the title product (1.75 g; 0.0085 mol). Yield, 85%; m.p. 76-77°C.
- b) By substituting ethylene glycol (100 ml) for n-butanol, 1,2-propanediol and water in the procedure of Example 3a, and otherwise heating the reaction mixture to 125°C for 16 hours and then following the procedure of Example 1 a, there is obtained the title product (1.64 g; 0.008 mol). Yield, 80%; m.p. 76-77°C.
- c) A mixture of 2 - (1' - bromoethyl) - 5,5 - dimethyl - 2 - (4' - isobutylphenyl) 1,3 - dioxane (3.55 g; 0.01 mol), potassium acetate (1.29 g; 0.012 mol) and cis - 2 - butene - 1,4 - diol (40 ml) is heated to 125°C for 3 hours.
- By following the procedure of Example 1a, there is obtained the title product (1.93 g; 0.0093 mol). Yield, 93%; m.p. 77°C.
- d) A mixture of 2-(1'- bromoethyl) - 2 - (4' - isobutylphenyl) -4,7 dihydro -1,3 dioxepine (3.39 g; 0.01 mol), potassium acetate (1.2 g; 0.012 mol) and ethylene glycol (50 ml) is heated to 115°C for 25 hours.
- By following the procedure of Example 1a, there is obtained the title compound (1.89 g; 0.0092 mol). Yield, 92%; m.p. 77°C.
- e) By substituting cis - 2 - butene - 1,4 - diol (40 ml) for ethylene glycol in the procedure of Example 3d, and otherwise heating the reaction mixture to 125°C for 3 hours and then following the procedure of Example 1a, there is obtained the title product (1.85 g; 0.009 mol). Yield, 90%, m.p. 76-77°C.
- f) A mixture of 2 - (1' - bromoethyl) - 5,5 - dimethyl - 2 - (4' - isobutyl) - 1,3 - dioxane (3.55 g; 0.01 mol), potassium acetate (1.2 g; 0.012 mol) and 2,2 - dimethyl -1,3 - propanediol (30 g) is heated to 150°C for 24 hours.
- By following the procedure of Example 1a, there is obtained the title product (1.4 g; 0.007 mol). Yield, 70% m.p. 76-77°C.
- g) A mixture of 2 - (1' - chloroethyl) - 5,5 - dimethyl - 2 - (4' - isobutylphenyl) - 1,3 - dioxane (68.4 g; 0.23 mol), ethylene glycol (92.5 ml), 2,2 - dimethyl - 1,3 - propanediol (36 g) and potassium acetate is heated to 195°C for 2 hours.
- The mixture is then cooled to 90°C and worked up as described in Example 1a to afford the title product (23.1 g; 0.112 mol). Yield, 48% m.p. 76-77°C.
- A mixture of 2 - bromoethyl - 2 - (4' - methoxyphenyl) - 4,7 - dihydro -1,3 - dioxepine (2.99 g; 0.01 mol), potassium acetate (1.2 g; 0.012 mol) and cis - 2 - butene - -1,4 - diol (40 ml) is heated to 125°C for 3 hours.
- By following the procedure of Example 1a, there is obtained the title product (1.5 g; 0.009 mol). Yield, 90%; m.p. 86-87°C.
- A mixture of 2 - (1 - bromoethyl) - 5,5 - dimethyl - 2 - (5' - bromo - 6' - methoxy - 2' - naphthyl) - 1,3 - dioxane (4.58 g; 0.01 mol), potassium acetate (1.2 g; 0.012 mol) and ethylene glycol (40 ml) is heated to 125°C for 24 hours.
- By following the procedure of Example 1 a, there is obtained the title product (2.8 g; 0.009 mol). Yield, 90%; m.p. 161-163°C.
- A mixture of 2 - (1' - bromoethyl) - 5,5 - dimethyl - 2 - (2' - thienyl) - 1,3 - dioxane (28.7 g; 0.094 mol), ethylene glycol (32.5 g; 0.52 mol), 2,2 - dimethyl - 1,3 - propanediol (13.75 g; 0.13 mol) and potassium acetate (10.25 g; 0.11 mol) is heated to 150°C for 5 hours.
- By following the procedure of Example 1a, there is obtained the title product (11.7 g; 0.075 mol). Yield, 80%; b.p. 98-100°C/0.5 mm Hg.
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT83201137T ATE17713T1 (en) | 1982-08-06 | 1983-08-01 | PROCESS FOR THE PREPARATION OF ALPHAARYLALKANES|URES. |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT2276082 | 1982-08-06 | ||
IT8222760A IT1210917B (en) | 1982-08-06 | 1982-08-06 | PROCEDURE FOR PREPARING ARYL-ALCANOIC ACID ESTERS. |
IT1993083 | 1983-03-07 | ||
IT8319930A IT1212709B (en) | 1983-03-07 | 1983-03-07 | ALPHA-HALOGENALKYLCHILES PARTICULARLY USEFUL FOR THE SYNTHESIS OF ALPHA-ARYLCALANIC ACIDS. |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0101124A1 EP0101124A1 (en) | 1984-02-22 |
EP0101124B1 true EP0101124B1 (en) | 1986-01-29 |
Family
ID=26327353
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP83201137A Expired EP0101124B1 (en) | 1982-08-06 | 1983-08-01 | Process for preparing alpha arylalkanoic acids |
Country Status (12)
Country | Link |
---|---|
US (1) | US4535166A (en) |
EP (1) | EP0101124B1 (en) |
KR (1) | KR880002308B1 (en) |
AU (2) | AU561838B2 (en) |
CA (1) | CA1205489A (en) |
DE (1) | DE3362024D1 (en) |
DK (1) | DK163427C (en) |
ES (1) | ES525463A1 (en) |
FI (1) | FI78456C (en) |
IE (1) | IE55697B1 (en) |
NO (1) | NO157735C (en) |
PT (1) | PT77158B (en) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3461525D1 (en) * | 1984-02-02 | 1987-01-15 | Zambon Spa | Process for preparing alpha-arylalkanoic acids |
IT1173216B (en) * | 1984-02-03 | 1987-06-18 | Zambon Spa | PROCESS FOR THE PREPARATION OF ALPHA-HYDROXYARYL-ALCANOIC ACIDS |
IT1173369B (en) * | 1984-02-24 | 1987-06-24 | Zambon Spa | PROCESS FOR THE PREPARATION OF OPTICALLY ACTIVE ALFA-ARILALCANOIC ACIDS |
DE3567209D1 (en) * | 1984-04-06 | 1989-02-09 | Zambon Spa | Optically active ketals, processes for their preparation and their use in the synthesis of apha-arylakanoic acids |
ES8700649A1 (en) * | 1984-07-11 | 1986-11-16 | Blaschim Spa | Process for the preparation of arylalkanoic acids by oxidative rearrangement of arylalkanones |
IT1180645B (en) * | 1984-10-15 | 1987-09-23 | Zambon Spa | INTERMEDIATES FOR THE SYNTHESIS OF CARBOXYLIC ACIDS |
IT1188181B (en) * | 1985-07-31 | 1988-01-07 | Zambon Spa | PROCESS FOR THE PREPARATION OF OPTICALLY ACTIVE AND INTERMEDIATE CARBOXYLIC ACIDS |
JPS62263153A (en) * | 1986-05-28 | 1987-11-16 | エフ・ホフマン―ラ ロシユ アーゲー | Carbazole derivative |
IT1198234B (en) * | 1986-12-23 | 1988-12-21 | Zambon Spa | STEREOCONVERGENT PROCESS FOR THE PREPARATION OF OPTICALLY ACTIVE CARBOXYLIC ACIDS |
IT1251958B (en) * | 1991-10-18 | 1995-05-27 | Zambon Spa | PROCESS FOR THE DEALOGENATION OF NAPHTHALENE DERIVATIVES |
US5556004A (en) * | 1994-11-01 | 1996-09-17 | Seal Spout Corporation | Ninety degree pouring spout |
DE102004005318A1 (en) * | 2004-02-04 | 2005-08-25 | Bayer Cropscience Ag | Process for the preparation of 2,5-dimethylphenylacetic acid |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1109200B (en) * | 1979-02-20 | 1985-12-16 | Montedison Spa | PROCESS FOR THE PREPARATION OF ARYLACETIC ACID ESTERS FROM ALPHA-ALO-ALCHYLARYL KETONES |
IE50898B1 (en) * | 1980-02-26 | 1986-08-06 | Blaschim Spa | Process for preparing esters of 2-(6'-methoxy-2'-naphthyl)-propionic acid via rearrangement of new ketals of 2-halo-1-(6'-methoxy-2'-naphthyl)-propan-1-one |
IT1167476B (en) * | 1981-07-23 | 1987-05-13 | Blasinachim Spa | PROCEDURE FOR PREPARING ALCANOIC ACIDS OR THEIR ESTERS BY ALTERNATION OF ALPHA-HALOGEN-KETONES IN A PROTIC MEANS AND IN THE PRESENCE OF A SALT OF A NON-NOBLE METAL |
IT1190741B (en) * | 1982-03-22 | 1988-02-24 | Blaschim Spa | PROCEDURE FOR PREPARING ACID ESTERS 2- (6'-METHOXY-2'-NAFTIL) -PROPIONIC |
-
1983
- 1983-08-01 EP EP83201137A patent/EP0101124B1/en not_active Expired
- 1983-08-01 DE DE8383201137T patent/DE3362024D1/en not_active Expired
- 1983-08-03 IE IE1837/83A patent/IE55697B1/en not_active IP Right Cessation
- 1983-08-03 US US06/520,131 patent/US4535166A/en not_active Expired - Lifetime
- 1983-08-04 FI FI832817A patent/FI78456C/en not_active IP Right Cessation
- 1983-08-04 PT PT77158A patent/PT77158B/en not_active IP Right Cessation
- 1983-08-05 CA CA000433947A patent/CA1205489A/en not_active Expired
- 1983-08-05 AU AU17650/83A patent/AU561838B2/en not_active Ceased
- 1983-08-05 ES ES525463A patent/ES525463A1/en not_active Expired
- 1983-08-05 DK DK358183A patent/DK163427C/en not_active IP Right Cessation
- 1983-08-05 NO NO832830A patent/NO157735C/en unknown
- 1983-08-05 AU AU17651/83A patent/AU563950B2/en not_active Ceased
- 1983-08-06 KR KR1019830003688A patent/KR880002308B1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
ES525463A1 (en) | 1985-02-01 |
KR880002308B1 (en) | 1988-10-22 |
DE3362024D1 (en) | 1986-03-13 |
FI832817A0 (en) | 1983-08-04 |
DK163427C (en) | 1992-11-16 |
PT77158A (en) | 1983-09-01 |
DK358183D0 (en) | 1983-08-05 |
AU561838B2 (en) | 1987-05-21 |
CA1205489A (en) | 1986-06-03 |
NO157735C (en) | 1988-05-11 |
AU1765083A (en) | 1984-02-09 |
US4535166A (en) | 1985-08-13 |
KR840006005A (en) | 1984-11-21 |
EP0101124A1 (en) | 1984-02-22 |
FI832817A (en) | 1984-02-07 |
AU563950B2 (en) | 1987-07-30 |
IE831837L (en) | 1984-02-06 |
PT77158B (en) | 1986-02-03 |
NO832830L (en) | 1984-02-07 |
IE55697B1 (en) | 1990-12-19 |
FI78456C (en) | 1989-08-10 |
AU1765183A (en) | 1984-09-13 |
DK358183A (en) | 1984-02-07 |
DK163427B (en) | 1992-03-02 |
FI78456B (en) | 1989-04-28 |
NO157735B (en) | 1988-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0101124B1 (en) | Process for preparing alpha arylalkanoic acids | |
US4560777A (en) | Preparation of esters of 2-(6'-methoxy-2'-naphthyl)-propionic acid via rearrangement of ketals of 2-halo-1-(6'-methoxy-2'-naphthyl)-propan-1-one | |
CA1314880C (en) | Thieno-1,4-diazepines | |
EP0150447A2 (en) | Substituted dihydrobenzopyran-2-carboxylates | |
US7629476B2 (en) | Method for producing 2,5-dimethylphenyl acetic acid | |
EP0597107B1 (en) | Lignan analog, production thereof, and hypolipidemic drug | |
IE64243B1 (en) | Derivatives of benzocycloalkenyldihydroxyalkanoic acids processes of preparation and medications containing them | |
Chiellini et al. | Polyesters based on glyceric acid derivatives as potential biodegradable materials | |
JP2002520407A (en) | Cyclic compounds, pharmaceutical compositions and methods of manufacture useful for treating dyslipidemia, atherosclerosis and diabetes | |
CZ280084B6 (en) | Derivatives of 2-(aminoalkyl)-5-(arylalkyl)-1,3-dioxanes, process for their preparation and pharmaceutical preparation in which said derivatives are comprised | |
JPH0454657B2 (en) | ||
EP0151817B1 (en) | Process for preparing alpha-arylalkanoic acids | |
CA1067074A (en) | 6',2-(2'-arylchromonyl)propionic acids | |
US4582930A (en) | Process for the preparation of optically active alpha-arylalkanoic acids | |
CA1257283A (en) | PROCESS FOR PREPARING .alpha.-SUBSTITUTED- ALKYLARYLKETALS | |
US4620031A (en) | Process for preparing alpha-aryl-alkanoic acids | |
JPS5989638A (en) | Manufacture of aryloxyalkyl compound | |
US4122200A (en) | 6',2-(2'Arylchromonyl) propionic acids, and analgesic and anti-inflammatory derivatives thereof | |
US5183924A (en) | Derivatives of benzocycloalkenyldihydroxyalkanoic acids, processes of preparation and medications containing them | |
WO1980000964A1 (en) | Anti-inflammatory agents including 2-carbonyl-3-hydroxy-2-alkenonitriles | |
EP0152003A1 (en) | Process for the preparation of alpha-hydroxyaryl-alkanoic acids |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
AK | Designated contracting states |
Designated state(s): AT BE CH DE FR GB IT LU NL SE |
|
17P | Request for examination filed |
Effective date: 19840807 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Designated state(s): AT BE CH DE FR GB IT LU NL SE |
|
REF | Corresponds to: |
Ref document number: 17713 Country of ref document: AT Date of ref document: 19860215 Kind code of ref document: T |
|
ITF | It: translation for a ep patent filed | ||
REF | Corresponds to: |
Ref document number: 3362024 Country of ref document: DE Date of ref document: 19860313 |
|
ET | Fr: translation filed | ||
PLBI | Opposition filed |
Free format text: ORIGINAL CODE: 0009260 |
|
26 | Opposition filed |
Opponent name: BLASCHIM S.P.A. Effective date: 19861029 |
|
NLR1 | Nl: opposition has been filed with the epo |
Opponent name: BLASCHIM S.P.A. |
|
PLBN | Opposition rejected |
Free format text: ORIGINAL CODE: 0009273 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: OPPOSITION REJECTED |
|
27O | Opposition rejected |
Effective date: 19891209 |
|
NLR2 | Nl: decision of opposition | ||
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: AT Payment date: 19930826 Year of fee payment: 11 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: LU Payment date: 19930831 Year of fee payment: 11 |
|
EPTA | Lu: last paid annual fee | ||
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 19940801 Ref country code: AT Effective date: 19940801 |
|
EAL | Se: european patent in force in sweden |
Ref document number: 83201137.3 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: BE Payment date: 20000627 Year of fee payment: 18 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20000726 Year of fee payment: 18 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: CH Payment date: 20000810 Year of fee payment: 18 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: SE Payment date: 20000816 Year of fee payment: 18 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20000829 Year of fee payment: 18 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: NL Payment date: 20000831 Year of fee payment: 18 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20001027 Year of fee payment: 18 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20010801 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20010802 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20010831 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20010831 Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20010831 |
|
BERE | Be: lapsed |
Owner name: ZAMBON S.P.A. Effective date: 20010831 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20020301 |
|
GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20010801 |
|
EUG | Se: european patent has lapsed |
Ref document number: 83201137.3 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20020430 |
|
NLV4 | Nl: lapsed or anulled due to non-payment of the annual fee |
Effective date: 20020301 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20020501 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: ST |
|
APAH | Appeal reference modified |
Free format text: ORIGINAL CODE: EPIDOSCREFNO |